₹ 17.06 Cr
0.21%
Nifty Healthcare TRI
INF740KA1UF4
5000.0
0.0
500
Anil Ghelani, Diipesh Shah, Neha Rathi
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| DSP Nifty Healthcare ETF | 7.38 | - | - |
| NIFTY Healthcare TRI | 7.63 | 20.42 | 13.45 |
Equity
Debt
Others
The Scheme seeks to provide returns that, before expenses, correspond to the total return of the underlying index (Nifty Healthcare TRI), subject to tracking errors. There is no assurance that the investment objective of the Scheme will be achieved.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 16.99 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 10.43 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.42 |
| LAURUS LABS LIMITED EQ NEW FV RS. 2/- | 6.81 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 6.69 |
| Dr. Reddys Laboratories Ltd | 6.64 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 6.24 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 6.11 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.36 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 4.08 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 99.92 |
| Scheme Name | 5Y (%) |
|---|---|
| DSP Nifty Healthcare ETF | 0.0 |